Lv63
2440 积分 2023-08-02 加入
Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging
2天前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
1个月前
已完结
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines
1个月前
已完结
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function
2个月前
已完结
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?
3个月前
已完结
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
4个月前
已完结
Long-Acting Factor XI Inhibition and Periprocedural Bleeding
4个月前
已关闭
Effect of heparins, DOACs, and FXII/FXI inhibitors on catheter-initiated thrombin generation in PRP: an in vitro study
4个月前
已关闭
EFFECTS OF MILVEXIAN ALONE OR WITH HEPARIN ON CATHETER-INDUCED CLOTTING AND THROMBIN GENERATION
4个月前
已关闭
Joint Associations of APOC3 and LDL-C–Lowering Variants With the Risk of Coronary Heart Disease
5个月前
已完结
皖公网安备34019202002308
